Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
DVT	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Pelvic	O
mass	O
biopsy	O
Thrombolysis	O
___	O
Common	O
iliac	O
stent	O
placement	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
female	O
with	O
a	O
past	O
medical	O
history	O
of	O
hypertension,	O
right	O
total	O
knee	O
replacement,	O
history	O
of	O
subarachnoid	B-Intracranial_haemorrhage
hemorrhage	B-Intracranial_haemorrhage
after	O
a	O
fall	B-Falls
and	O
family	O
history	O
of	O
Factor	O
V	O
Leiden	O
mutation	O
who	O
presents	O
to	O
emergency	O
department	O
as	O
a	O
transfer	O
from	O
outside	O
hospital	O
with	O
right	O
leg	O
DVT.	O
Patient	O
states	O
that	O
approximately	O
2	O
weeks	O
ago,	O
she	O
developed	O
pain	O
in	O
her	O
right	O
calf	O
which	O
she	O
describes	O
as	O
crampy.	O
Per	O
patient,	O
she	O
was	O
evaluated	O
in	O
the	O
emergency	O
department	O
then	O
with	O
a	O
negative	O
lower	O
extremity	O
ultrasound.	O
Pain	O
never	O
went	O
completely	O
away	O
and	O
started	O
to	O
get	O
progressively	O
worse.	O
About	O
3	O
days	O
ago,	O
she	O
also	O
developed	O
crampy	O
pain	O
in	O
her	O
right	O
thigh	O
with	O
subjective	O
fevers.	O
She	O
is	O
not	O
experiencing	O
any	O
other	O
symptoms.	O
Denies	O
any	O
shortness	O
of	O
breath,	O
chest	O
pain,	O
abdominal	O
pain.	O
She	O
denies	O
any	O
recent	O
surgeries,	O
recent	O
travels,	O
and	O
mobilities.	O
At	O
___	O
earlier	O
today,	O
US	O
of	O
RLE	O
showed	O
DVT	O
of	O
R	O
CEIV,	O
CFV,	O
SFV,	O
___	O
deep	O
femoral,	O
PTV,	O
peroneal	O
veins.	O
She	O
was	O
started	O
on	O
heparin	O
drip	O
and	O
transferred	O
to	O
___	O
for	O
Vascular	O
surgery	O
consult	O
and	O
consideration	O
of	O
thrombectomy.	O
In	O
our	O
ED:	O
VS:	O
Tmax	O
101.7,	O
P	O
82,	O
BP	O
154/74,	O
RR	O
18,	O
pOx	O
98%	O
RA	O
PE:	O
swelling	O
of	O
right	O
thigh	O
and	O
calf	O
ECG:	O
NSR	O
at	O
78	O
bpm,	O
no	O
S1Q3T3	O
pattern	O
Labs:	O
.	O
CBC:	O
13	O
>	O
13	O
/	O
40	O
<	O
221,	O
MCV	O
89,	O
78.8%	O
PMNs,	O
INR	O
1.2,	O
PTT	O
111	O
.	O
BMP:	O
142	O
/	O
4.6	O
//	O
102	O
/	O
24	O
//	O
15	O
/	O
0.6	O
<	O
127;	O
AG	O
16	O
Imaging:	O
CXR	O
negative,	O
US	O
from	O
OSH	O
uploaded	O
into	O
system	O
Interventions:	O
1g	O
Tylenol	O
po,	O
heparin	O
IV	O
gtt,	O
2mg	O
IV	O
morphine,	O
BCx	O
x2	O
Vascular	O
was	O
consulted	O
in	O
the	O
ED	O
with	O
recs	O
as	O
follows:	O
___	O
w/RLE	O
DVT	O
and	O
swelling	O
of	O
thigh	O
and	O
calf	O
w/US	O
showing	O
DVT	O
of	O
R	O
CEIV,	O
CFV,	O
SFV,	O
___	O
deep	O
femoral,	O
PTV,	O
peroneal	O
veins	O
[]	O
admit	O
to	O
med	O
[]	O
hep	O
gtt	O
[]	O
hypercoag	O
work	O
up	O
(fam	O
hx	O
of	O
factor	O
V	O
leiden)	O
[]	O
ace	O
wrap/elevate	O
[]	O
monitor	O
fevers	O
ok	O
for	O
diet.	O
will	O
contact	O
medicine	O
with	O
changes	O
On	O
arrival	O
to	O
the	O
floor,	O
patient	O
denied	O
any	O
pain	O
stating	O
that	O
her	O
pain	O
was	O
at	O
a	O
___	O
previously	O
but	O
resolved	O
after	O
IV	O
morphine	O
which	O
she	O
received	O
in	O
the	O
ED.	O
States	O
that	O
she	O
has	O
been	O
having	O
pain	O
for	O
the	O
past	O
week	O
at	O
least	O
related	O
to	O
her	O
lower	O
extremity	O
swelling.	O
She	O
is	O
not	O
on	O
any	O
pain	O
meds	O
in	O
the	O
outpatient	O
setting.	O
She	O
denies	O
shortness	O
of	O
breath,	O
palpitations	O
or	O
chest	O
pain.	O
She	O
denies	O
recent	O
immobility,	O
recent	O
surgery	O
or	O
travel.	O
Besides	O
hypothyroidism	O
and	O
hypertension	O
she	O
stats	O
that	O
she	O
is	O
otherwise	O
healthy,	O
independent	O
in	O
all	O
her	O
ADLs	O
and	O
quite	O
active.	O
Her	O
daughter	O
has	O
history	O
of	O
recurrent	O
DVTs	O
and	O
was	O
found	O
to	O
have	O
Factor	O
V	O
Leiden	O
mutation.	O
Her	O
other	O
daughter	O
was	O
tested	O
at	O
the	O
time	O
and	O
found	O
to	O
also	O
have	O
Factor	O
V	O
Leiden	O
mutation	O
but	O
has	O
never	O
had	O
any	O
VTE.	O
Patient	O
herself	O
has	O
never	O
been	O
tested	O
for	O
any	O
testing	O
done	O
and	O
denies	O
personal	O
history	O
of	O
DVT/PE	O
prior	O
to	O
this	O
presentation.	O
Past	O
Medical	O
History:	O
-	O
HTN	O
-	O
Hypothyroidism	O
-	O
R	O
total	O
knee	O
replacement	O
-	O
SAH	B-Intracranial_haemorrhage
s/p	O
fall	B-Falls
Social	O
History:	O
___	O
Family	O
History:	O
Unknown	O
Physical	O
Exam:	O
ADMISSION	O
EXAM:	O
VITALS:	O
Afebrile	O
and	O
vital	O
signs	O
stable	O
(see	O
eFlowsheet)	O
GENERAL:	O
Alert	O
and	O
in	O
no	O
apparent	O
distress	O
EYES:	O
Anicteric,	O
pupils	O
equally	O
round	O
ENT:	O
Ears	O
and	O
nose	O
without	O
visible	O
erythema,	O
masses,	O
or	O
trauma.	O
Oropharynx	O
without	O
visible	O
lesion,	O
erythema	O
or	O
exudate	O
CV:	O
Heart	O
regular,	O
no	O
murmur,	O
no	O
S3,	O
no	O
S4.	O
No	O
JVD.	O
RESP:	O
Lungs	O
clear	O
to	O
auscultation	O
with	O
good	O
air	O
movement	O
bilaterally.	O
Breathing	O
is	O
non-labored	O
GI:	O
Abdomen	O
soft,	O
non-distended,	O
non-tender	O
to	O
palpation.	O
Bowel	O
sounds	O
present.	O
No	O
HSM	O
GU:	O
No	O
suprapubic	O
fullness	O
or	O
tenderness	O
to	O
palpation	O
MSK:	O
Neck	O
supple,	O
moves	O
all	O
extremities,	O
strength	O
grossly	O
full	O
and	O
symmetric	O
bilaterally	O
in	O
all	O
limbs	O
SKIN:	O
No	O
rashes	O
or	O
ulcerations	O
noted	O
NEURO:	O
Alert,	O
oriented,	B-Delirium
face	O
symmetric,	O
gaze	O
conjugate	O
with	O
EOMI,	O
speech	O
fluent,	O
moves	O
all	O
limbs,	O
sensation	O
to	O
light	O
touch	O
grossly	O
intact	O
throughout	O
PSYCH:	O
pleasant,	O
appropriate	O
affect	O
DISCHARGE	O
EXAM:	O
PHYSICAL	O
EXAM:	O
VS	O
-98.2,	O
145/75,	O
66,	O
18,	O
97%	O
RA	O
Gen:	O
Well-developed,	O
well-nourished,	O
NAD	O
HEENT:	O
EOMI,	O
PERRLA,	O
MMM,	O
no	O
conjunctival	O
pallor,	O
no	O
scleral	O
icterus,	O
no	O
thyromegaly,	O
no	O
overt	O
lymphadenopathy;	O
mildly	O
enlarged	O
non-mobile	O
R	O
cervical	O
lymph	O
node	O
to	O
palpation.	O
CV:	O
RRR,	O
nl	O
S1	O
S2,	O
no	O
m/r/g	O
PULM:	O
CTA	O
b/l,	O
no	O
w/r/c	O
Abd:	O
BS	O
normoactive,	O
S/ND/NT,	O
no	O
HSM,	O
no	O
guarding/rebound,	O
no	O
inguinal	O
LN	O
Ext:	O
WWP,	O
RLE	O
trace	O
pitting	O
edema,	O
mildly	O
improved	O
over	O
yesterday	O
Skin:	O
No	O
rash	O
Neuro:	O
A&Ox3,	B-Delirium
CNs	O
grossly	O
intact.	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
06:52AM	O
BLOOD	O
WBC-11.1*	O
RBC-4.13	O
Hgb-12.3	O
Hct-36.6	O
MCV-89	O
MCH-29.8	O
MCHC-33.6	O
RDW-12.5	O
RDWSD-41.1	O
Plt	O
___	O
___	O
06:52AM	O
BLOOD	O
Glucose-104*	O
UreaN-11	O
Creat-0.6	O
Na-144	O
K-4.3	O
Cl-103	O
HCO3-25	O
AnGap-16	O
___	O
06:52AM	O
BLOOD	O
ALT-28	O
AST-19	O
LD(LDH)-190	O
AlkPhos-92	O
TotBili-0.3	O
___	O
07:37AM	O
BLOOD	O
Calcium-8.9	O
Phos-3.4	O
Mg-2.1	O
___	O
06:52AM	O
BLOOD	O
UricAcd-3.6	O
IMAGING/DIAGNOSTIC	O
TESTS:	O
CTV	O
CT	O
VENOGRAM:	O
There	O
is	O
approximately	O
4.5	O
x	O
4.8	O
x	O
4.3	O
cm	O
enhancing	O
mass	O
in	O
the	O
right	O
hemipelvis	O
compressing	O
the	O
proximal	O
right	O
external	O
iliac	O
vein	O
just	O
distal	O
to	O
the	O
iliac	O
bifurcation	O
(series	O
4,	O
image	O
98;	O
series	O
6,	O
image	O
49).	O
There	O
is	O
a	O
filling	O
defect	O
in	O
the	O
right	O
external	O
iliac	O
vein	O
distal	O
to	O
the	O
mass	O
that	O
extends	O
into	O
the	O
right	O
common	O
femoral	O
vein	O
and	O
further	O
into	O
the	O
superficial	O
and	O
deep	O
femoral	O
veins.	O
There	O
is	O
wall	O
thickening,	O
wall	O
hyperemia,	O
and	O
extensive	O
adjacent	O
fat	O
stranding	O
associated	O
with	O
these	O
veins,	O
suggesting	O
acute/subacute	O
thrombosis.	O
Also	O
noted	O
is	O
extensive	O
edema	O
in	O
the	O
right	O
lower	O
extremity	O
from	O
venous	O
outflow	O
obstruction.	O
Arterial	O
flow	O
to	O
the	O
right	O
lower	O
extremity	O
is	O
preserved.	O
Proximal	O
to	O
the	O
mass	O
the	O
common	O
iliac	O
vein	O
is	O
patent.	O
The	O
inferior	O
vena	O
cava	O
and	O
the	O
left	O
common	O
femoral	O
vein	O
and	O
its	O
major	O
branches	O
are	O
patent.	O
LOWER	O
CHEST:	O
Partially	O
imaged	O
lung	O
bases	O
are	O
clear.	O
No	O
pleural	O
effusion.	O
ABDOMEN:	O
HEPATOBILIARY:	O
The	O
liver	O
demonstrates	O
homogenous	O
attenuation	O
throughout.	O
There	O
is	O
no	O
evidence	O
of	O
focal	O
lesions.	O
There	O
is	O
no	O
evidence	O
of	O
intrahepatic	O
or	O
extrahepatic	O
biliary	O
dilatation.	O
The	O
gallbladder	O
is	O
within	O
normal	O
limits.	O
PANCREAS:	O
The	O
pancreas	O
has	O
normal	O
attenuation	O
throughout,	O
without	O
evidence	O
of	O
focal	O
lesions	O
or	O
pancreatic	O
ductal	O
dilatation.	O
There	O
is	O
no	O
peripancreatic	O
stranding.	O
SPLEEN:	O
The	O
spleen	O
shows	O
normal	O
size	O
and	O
attenuation	O
throughout,	O
without	O
evidence	O
of	O
focal	O
lesions.	O
Accessory	O
spleens	O
are	O
noted.	O
ADRENALS:	O
The	O
right	O
and	O
left	O
adrenal	O
glands	O
are	O
normal	O
in	O
size	O
and	O
shape.	O
URINARY:	O
The	O
kidneys	O
are	O
of	O
normal	O
and	O
symmetric	O
size	O
with	O
normal	O
nephrogram.	O
Millimetric	O
hypodensities	O
in	O
the	O
right	O
kidney	O
are	O
too	O
small	O
to	O
characterize	O
but	O
statistically	O
likely	O
represent	O
cysts.	O
There	O
is	O
no	O
evidence	O
of	O
focal	O
renal	O
lesions	O
or	O
hydronephrosis.	O
There	O
is	O
no	O
perinephric	O
abnormality.	O
The	O
right	O
ureter	O
is	O
displaced	O
medially	O
by	O
the	O
pelvic	O
mass	O
however	O
there	O
is	O
no	O
evidence	O
of	O
hydroureter	O
or	O
hydronephrosis	O
to	O
suggest	O
obstruction.	O
GASTROINTESTINAL:	O
There	O
is	O
a	O
moderate-sized	O
hiatal	O
hernia.	O
The	O
stomach	O
is	O
mildly	O
distended	O
with	O
ingested	O
material.	O
Small	O
bowel	O
loops	O
demonstrate	O
normal	O
caliber,	O
wall	O
thickness,	O
and	O
enhancement	O
throughout.	O
There	O
is	O
mild	O
colonic	O
diverticulosis	O
without	O
evidence	O
of	O
acute	O
diverticulitis.	O
The	O
appendix	O
is	O
normal.	O
PELVIS:	O
The	O
urinary	O
bladder	O
and	O
distal	O
ureters	O
are	O
unremarkable.	O
There	O
is	O
no	O
free	O
fluid	O
in	O
the	O
pelvis.	O
REPRODUCTIVE	O
ORGANS:	O
There	O
is	O
a	O
mass	O
in	O
the	O
right	O
hemipelvis	O
adjacent	O
to	O
the	O
external	O
iliac	O
artery	O
and	O
vein	O
as	O
described	O
above.	O
The	O
exact	O
origin	O
of	O
the	O
mass	O
remains	O
unclear.	O
The	O
uterus	O
is	O
grossly	O
unremarkable.	O
The	O
ovaries	O
are	O
not	O
discretely	O
visualized.	O
LYMPH	O
NODES:	O
A	O
few	O
prominent	O
retroperitoneal	O
lymph	O
nodes	O
measure	O
up	O
to	O
8	O
mm	O
(Series	O
4,	O
image	O
68).	O
Aside	O
from	O
the	O
large	O
right	O
pelvic	O
mass	O
there	O
is	O
no	O
evidence	O
of	O
pelvic	O
or	O
inguinal	O
lymphadenopathy.	O
A	O
borderline	O
enlarged	O
anterior	O
right	O
thigh	O
lymph	O
measuring	O
10	O
x	O
13	O
mm	O
may	O
be	O
reactive.	O
VASCULAR:	O
There	O
is	O
no	O
abdominal	O
aortic	O
aneurysm.	O
Mild	O
atherosclerotic	O
disease	O
is	O
noted.	O
BONES:	O
There	O
is	O
no	O
evidence	O
of	O
worrisome	O
osseous	O
lesions	O
or	O
acute	O
fracture.	O
Degenerative	O
changes	O
in	O
the	O
spine	O
are	O
noted.	O
SOFT	O
TISSUES:	O
There	O
is	O
a	O
small	O
fat	O
containing	O
umbilical	O
hernia.	O
IMPRESSION:	O
1.	O
4.5	O
x	O
4.8	O
x	O
4.3	O
cm	O
solid	O
mass	O
in	O
the	O
right	O
hemipelvis,	O
of	O
unclear	O
origin.	O
2.	O
The	O
mass	O
compresses	O
the	O
right	O
external	O
iliac	O
vein	O
with	O
thrombosis	O
of	O
the	O
distal	O
portion	O
of	O
the	O
right	O
external	O
iliac	O
vein	O
extending	O
into	O
the	O
common	O
femoral	O
and	O
visualized	O
portions	O
of	O
the	O
superficial	O
and	O
deep	O
femoral	O
veins.	O
The	O
right	O
external	O
iliac	O
vein	O
proximal	O
to	O
the	O
mass,	O
left	O
external	O
iliac	O
vein,	O
and	O
inferior	O
vena	O
cava	O
are	O
patent.	O
3.	O
Venous	O
outflow	O
obstruction	O
results	O
in	O
extensive	O
edema	O
in	O
the	O
right	O
lower	O
extremity.	O
4.	O
Moderate	O
size	O
hiatal	O
hernia.	O
Pelvis	O
U/S	O
IMPRESSION:	O
5	O
cm	O
solid	O
right	O
pelvic	O
mass	O
with	O
internal	O
vascularity	O
is	O
of	O
uncertain	O
etiology.	O
This	O
is	O
more	O
superior	O
than	O
would	O
be	O
expected	O
of	O
a	O
primary	O
ovarian	O
lesion,	O
although	O
an	O
ovarian	O
lesion	O
cannot	O
be	O
entirely	O
excluded.	O
Neither	O
normal	O
ovary	O
is	O
visualized.	O
DISCHARGE	O
LABS:	O
___	O
12:00AM	O
BLOOD	O
WBC-20.2*	O
RBC-3.13*	O
Hgb-9.4*	O
Hct-28.0*	O
MCV-90	O
MCH-30.0	O
MCHC-33.6	O
RDW-13.3	O
RDWSD-41.6	O
Plt	O
___	O
___	O
12:00AM	O
BLOOD	O
Plt	O
___	O
___	O
12:00AM	O
BLOOD	O
___	O
PTT-32.6	O
___	O
___	O
12:00AM	O
BLOOD	O
___	O
12:00AM	O
BLOOD	O
Glucose-77	O
UreaN-11	O
Creat-0.6	O
Na-143	O
K-4.1	O
Cl-104	O
HCO3-22	O
AnGap-17*	O
___	O
12:00AM	O
BLOOD	O
ALT-26	O
AST-22	O
LD(LDH)-414*	O
AlkPhos-117*	O
TotBili-0.2	O
___	O
12:00AM	O
BLOOD	O
Albumin-3.4*	O
Calcium-9.0	O
Phos-3.1	O
Mg-2.2	O
UricAcd-2.2*	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
female	O
with	O
a	O
past	O
medical	O
history	O
of	O
hypertension,	O
right	O
total	O
knee	O
replacement,	O
history	O
of	O
subarachnoid	B-Intracranial_haemorrhage
hemorrhage	B-Intracranial_haemorrhage
after	O
a	O
fall	B-Falls
and	O
family	O
history	O
of	O
Factor	O
V	O
Leiden	O
mutation	O
who	O
presented	O
as	O
a	O
transfer	O
from	O
outside	O
hospital	O
with	O
extensive	O
RLE	O
DVT	O
for	O
Vascular	O
Surgery	O
consult.	O
========================	O
ACTIVE	O
ISSUES	O
ADDRESSED:	O
========================	O
#Deep	O
Vein	O
Thrombosis	O
Patient	O
presented	O
to	O
outside	O
hospital	O
with	O
right	O
lower	O
extremity	O
DVT.	O
She	O
was	O
evaluated	O
by	O
interventional	O
radiology	O
who	O
performed	O
thrombectomy	O
and	O
stent	O
placement	O
on	O
___.	O
She	O
was	O
initially	O
started	O
on	O
heparin	O
and	O
then	O
transitioned	O
to	O
Lovenox	O
therapeutic	O
dosing.	O
Lower	O
extremity	O
swelling	O
reduced	O
and	O
patient	O
never	O
developed	O
signs	O
or	O
symptoms	O
of	O
pulmonary	O
embolism.	O
Factor	O
V	O
Leiden	O
testing	O
was	O
deferred	O
given	O
provoked	O
nature	O
of	O
DVT	O
given	O
active	O
malignancy	O
and	O
compression	O
of	O
right	O
external	O
iliac	O
vein	O
by	O
pelvic	O
mass.	O
#B-cell	O
Lymphoma	O
Imaging	O
showed	O
pelvic	O
mass	O
compressing	O
right	O
external	O
iliac	O
vein,	O
CT-guided	O
___	O
biopsy	O
was	O
performed	O
which	O
showed	O
B-cell	O
lymphoma.	O
Patient	O
was	O
initiated	O
on	O
R	O
CHOP	O
therapy	O
on	O
___	O
and	O
monitored	O
for	O
complications	O
which	O
she	O
did	O
not	O
develop.	O
Tumor	O
lysis	O
labs	O
negative.	O
Follow-up	O
was	O
established	O
with	O
___	O
___	O
oncology	O
with	O
the	O
final	O
pathology	O
pending	O
at	O
the	O
time	O
of	O
discharge.	O
___	O
to	O
be	O
contacted	O
when	O
final	O
pathology	O
available	O
and	O
results	O
forwarded	O
to	O
inform	O
subsequent	O
treatment	O
and	O
overall	O
management	O
plan.	O
========================	O
CHRONIC/STABLE	O
PROBLEMS:	O
========================	O
#	O
Hypertension	O
Patient	O
was	O
continued	O
on	O
home	O
BP	O
medications	O
with	O
good	O
control.	O
#	O
Hypothyroidism	O
-	O
continue	O
home	O
synthroid	O
Patient	O
continued	O
on	O
home	O
synthroid.	O
=====================	O
TRANISITIONAL	O
ISSUES:	O
=====================	O
[	O
]	O
New	O
medications	O
--	O
Prednisone:	O
100mg	O
QD	O
2	O
doses	O
-	O
part	O
of	O
chemotherapy	O
regimen	O
--	O
Neupogen:	O
300mcg	O
qd	O
-	O
to	O
increase	O
rate	O
of	O
cell	O
count	O
return	O
--	O
Lovenox	O
___	O
qd	O
-	O
to	O
treat	O
and	O
prevent	O
blood	O
clots	O
--	O
Acyclovir	O
400mg	O
q8	O
-	O
to	O
prevent	O
shingles	O
while	O
on	O
chemo	O
--	O
Allopurinol	O
___	O
qd	O
-	O
protection	O
of	O
kidneys	O
while	O
on	O
chemo	O
--	O
Ranitidine:	O
75mg	O
QD	O
-	O
prevention	O
of	O
ulcers	O
while	O
on	O
steroids	O
--	O
Senna/PEG:	O
PRN	O
-	O
to	O
treat	O
constipation	B-Constipation
--	O
Ondansetron	O
4mg	O
Q8	O
PRN	O
-	O
to	O
treat	O
nausea	O
--	O
Prochlorperazine	O
10mg	O
Q6	O
PRN	O
-	O
to	O
treat	O
nausea	O
[	O
]	O
Follow	O
up	O
with	O
Primary	O
Care	O
Physician	O
--	O
___	O
should	O
be	O
continued	O
for	O
6	O
months	O
after	O
which	O
a	O
discussion	O
can	O
be	O
held	O
about	O
continuing	O
for	O
provoked	O
DVT	O
and	O
the	O
role	O
of	O
testing	O
for	O
Factor	O
V	O
Leiden.	O
[	O
]	O
Follow	O
up	O
with	O
___	O
Oncology	O
department	O
--	O
Patient	O
pathology	O
for	O
LN	O
biopsy	O
and	O
BM	O
biopsy	O
are	O
both	O
pending	O
--	O
Please	O
follow	O
up	O
on	O
pathology	O
for	O
both	O
for	O
staging	O
[	O
]	O
Please	O
transfuse	O
to	O
goal	O
of	O
plt	O
>50	O
to	O
allow	O
lovenox	O
use.	O
CODE:	O
Full	O
Code	O
Contact:	O
___	O
(daughter)	O
___	O
___	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
2.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
5X/WEEK	O
(___)	O
3.	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
PO	O
2X/WEEK	O
(WE,SA)	O
Discharge	O
Medications:	O
1.	O
Acyclovir	O
400	O
mg	O
PO	O
Q8H	O
RX	O
*acyclovir	O
400	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
three	O
times	O
a	O
day	O
Disp	O
#*90	O
Tablet	O
Refills:*0	O
2.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
RX	O
*allopurinol	O
___	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
3.	O
Enoxaparin	O
Sodium	O
100	O
mg	O
SC	O
Q24H	O
Start:	O
___,	O
First	O
Dose:	O
Next	O
Routine	O
Administration	O
Time	O
RX	O
*enoxaparin	O
100	O
mg/mL	O
100	O
mg	O
subcutaneous	O
once	O
a	O
day	O
Disp	O
#*14	O
Syringe	O
Refills:*1	O
4.	O
Filgrastim-sndz	O
300	O
mcg	O
SC	O
Q24H	O
RX	O
*filgrastim	O
[Neupogen]	O
300	O
mcg/0.5	O
mL	O
300	O
mcg	O
subcutaneous	O
once	O
a	O
day	O
Disp	O
#*10	O
Syringe	O
Refills:*1	O
5.	O
Ondansetron	O
4	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
RX	O
*ondansetron	O
HCl	O
4	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
eight	O
(8)	O
hours	O
Disp	O
#*42	O
Tablet	O
Refills:*0	O
6.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
constipation	B-Constipation
RX	O
*polyethylene	O
glycol	O
3350	O
17	O
gram	O
1	O
powder(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*30	O
Packet	O
Refills:*0	O
7.	O
PredniSONE	O
100	O
mg	O
PO	O
Q24H	O
Duration:	O
2	O
Doses	O
Please	O
take	O
2	O
doses	O
to	O
complete	O
a	O
5	O
day	O
course.	O
RX	O
*prednisone	O
50	O
mg	O
2	O
tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*4	O
Tablet	O
Refills:*0	O
8.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q6H:PRN	O
nausea	O
RX	O
*prochlorperazine	O
maleate	O
10	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
six	O
(6)	O
hours	O
Disp	O
#*60	O
Tablet	O
Refills:*0	O
9.	O
Ranitidine	O
75	O
mg	O
PO	O
DAILY	O
RX	O
*ranitidine	O
HCl	O
75	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
10.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
Constipation	B-Constipation
RX	O
*sennosides	O
[senna]	O
8.6	O
mg	O
1	O
tablet	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
11.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
12.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
5X/WEEK	O
(___)	O
13.	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
PO	O
2X/WEEK	O
(WE,SA)	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnosis:	O
B-cell	O
Lymphoma	O
Deep	O
Vein	O
Thrombosis	O
Secondary	O
Diagnosis:	O
Hypertension	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___.	O
WHY	O
DID	O
YOU	O
COME	O
TO	O
THE	O
HOSPITAL?	O
-	O
You	O
were	O
brought	O
to	O
the	O
hospital	O
because	O
of	O
a	O
clot	O
in	O
your	O
right	O
leg	O
veins.	O
WHAT	O
HAPPENED	O
WHILE	O
YOU	O
WERE	O
HERE?	O
-	O
The	O
clot	O
in	O
your	O
right	O
leg	O
veins	O
was	O
removed	O
and	O
you	O
were	O
started	O
on	O
a	O
blood	O
thinner.	O
-	O
An	O
imaging	O
scan	O
showed	O
a	O
mass	O
in	O
your	O
right	O
pelvis,	O
and	O
a	O
biopsy	O
of	O
the	O
mass	O
showed	O
lymphoma.	O
-	O
You	O
were	O
started	O
on	O
chemotherapy	O
for	O
your	O
lymphoma	O
and	O
monitored	O
for	O
side	O
effects.	O
WHAT	O
SHOULD	O
YOU	O
DO	O
WHEN	O
YOU	O
LEAVE	O
THE	O
HOSPITAL?	O
-	O
Please	O
continue	O
to	O
take	O
all	O
of	O
your	O
medications	O
as	O
directed,	O
and	O
follow	O
up	O
with	O
all	O
of	O
your	O
doctors.	O
Again,	O
it	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you!	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

